Agilent's Projected Q3 Revenue Decline Improves Original Forecast | GenomeWeb

Agilent's Projected Q3 Revenue Decline Improves Original Forecast

Jun 07, 2007

NEW YORK (GenomeWeb News) — Agilent Technologies today said it expects third-quarter revenue to decline between 2 percent and 4.8 percent year over year, though it is a 1.5-percent improvement over earlier predictions.

During its fiscal second quarter earnings report in May, Agilent had said it expected third-quarter revenue to decline between 3.5 percent and 6.2 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Suspect Confesses in Killing of Developmental Biologist

A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

Concerning Links

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

For Coverage

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

PNAS Studies Tackle Syndromic Craniosynostosis, Colorectal Cancer Drivers, More

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.